Status of Hadrontherapy facilities worldwide

Size: px
Start display at page:

Download "Status of Hadrontherapy facilities worldwide"

Transcription

1 Status of Hadrontherapy facilities worldwide Vienna The Gantry 1 of PSI Eros Pedroni Center for Proton Radiation Therapy Paul Scherrer Institute SWITZERLAND Author s competence: Gantry with proton pencil beam scanning High LET radiation - with pion therapy 1

2 Outline of the presentation 1. Motivation for Hadrontherapy Physical selectivity Radiobiology of High LET radiation 2. Scanning beams vs. passive scattering 3. Tour of the world of the hadrontherapy facilities 4. The point of view of PSI: past experience and future plans 5. New accelerator concepts 6. Conclusions 2

3 1. Hadrontherapy: the context 3

4 Hadrontherapy HT = Radiotherapy (RT) using protons and ion beams The term of comparison for hadron-therapy: Conventional radiotherapy (RT) with photons With new dynamic beam delivery techniques Intensity Modulated RT (IMRT) Tomotherapy Treatment of moving tumors Respiration gated irradiations Use of time resolved images 4d-CT and 4d-MRI Image-guided radiotherapy Beam delivery adaptation on line 4

5 1A. Physical selectivity goal Protons Proton beams: the best external radiation therapy with low-let 5

6 The rationale for using protons Physical selectivity Finite range Bragg peak Photons Protons (and ions) SOBP dose depth (cm) depth (cm) No significant radiobiological difference between protons and photons Main advantage of protons compared to photons the distribution of the dose Dose burden on the healthy tissues outside of the target volume reduced by a factor 2 to 5 6

7 1B. Different radiobiology heavier (light) ions Carbon ion: the best external radiation therapy with high-let 7

8 What is high-let radiation? LET (LET - Linear energy transfer ionization density Relevant at the size of the DNA structure Low LET at low doses -> single damage to the DNA chain -> Repair High LET -> multiple damages to the DNA chain -> NO repair High LET: means DNA For the tumor cells Increased efficiency of killing BULLET For the healthy tissues Increased collateral damage?? Acute effects Late effects vs. Secondary cancer induction Sensitive tissues within or outside of the target? CANNON BALL X-rays Protons Ions (a wikipedia image) 8

9 The strength of carbon ions: High LET with very good physical selectivity Improved ballistic precision Low multiple Coulomb scattering Improved lateral precision Sharper Bragg peak But loss of primary beam Fractionation tails Interesting: for the future The use of helium ions a low enough low-let radiation for the highest precision? 9

10 2. Technical options Gantry vs. Horizontal beam Scanning beams vs. passive scattering 10

11 The price to pay for the ions : the increased size of the facility 70m Carbon ions The magnetic rigidity of the beam Carbon ions 3 times higher than protons Size increased by a factor of 2 in all dimensions Costs doubled No gantry or a huge gantry Or a dedicated proton gantry 37m Protons 11

12 Passive scattering The established traditional method (of the 60s) range-shifter wheel collimator patient target volume scatter foils entrance dose 100% dose compensator Not truly 3d-conformal (fixed modulation of the range) Field specific hardware needed for each field IMRT difficult (if not unfeasible) Less sensitive to organ motion errors than scanning 12

13 Pencil beam scanning DEPTH ~ 20 cm Lateral position Fully 3d conformal (variable range modulation) Better dose precision - less material in the nozzle Fully automated (no specific hardware needed) Clean beam: less activation, less neutron background 13

14 Advantage of using a scanning gantry: IMPT Flexibility to shape the dose distribution within the field Simultaneous optimization of fields Intensity modulated therapy IMPT (40% of the PSI treatments) Attract large interest due to competition with photon IMRT Biological targeting (non-uniform dose distribution) Disadvantage of scanning Sensitivity to organ motion Need to develop Faster scanning Repainting Gating Tracking 14

15 3. Tour of the world of hadrontherapy facilities 15

16 EYE treatments - dedicated - at low energy EUROPE PSI, Villigen Switzerland p OPTIS2 since Nov 2010) Clatterbridge England p Nice France p HZB (HMI), Berlin Germany p INFN-LNS, Catania Italy p NORTH AMERICA UCSF San Francisco USA p TRIUMF, Vancouver Canada p Comment: Place of origin Boston (Harvard) p150 since the 80's The largest amount of treated patients with Proton Therapy A rare disease 16

17 RUNNING FACILITIES in the world USA Type Rooms Acc. Start Pats. Company Loma Linda CA p 250 3g1h synchr Optivus NPTC, MGH Boston p 235 2g1h cycl IBA MPRI(2) Bloomington p 200 2g1h cycl IBA MDA Houston p250 3g1h synchr Hitachi spread beam and beam scanning since 2008 UFPTI Jacksonville p 230 3g1h, cycl IBA ProCure Oklahoma p 230 1gh2h/60 cycl IBA UPenn, Philadelphia p 230 4g1h cycl IBA CDH, Warrenville, IL p 230 1g1h2h/60 cycl 2010 started IBA Boston (previously Harvard cyclotron) has provided most of the clinical evidence for PT Loma Linda has been the first hospital-based proton facility in the world (15000 patients) In the USA we have only proton facilities mainly cyclotrons All facilities use proton gantries and scattering Scanning is being developed as an addition to scattering (for competing with IMRT) No ion therapy in the US since the shutting down of the Berkeley facility 17

18 RUNNING FACILITIES in the world JAPAN Type Rooms Acc. Start Pats. Company HIMAC, Chiba C800 1h1hv sync, many NCC, Kashiwa p235 2g cycl Sumitomo HIBMC,Hyogo p230 2g sync Mitsubishi HIBMC,Hyogo C320 1h1v sync Mitsubishi PMRC Tsukuba p250 2g sync Hitachi Shizuoka p235 gh sync, Hitachi? WakasaTsuruga p200 1h1v sync ? GHMC, Gunma C400 3h1v sync started? compact Chiba: was the first dedicated facility using only carbon ions The place producing the most important clinical results with carbon (5500 patients) With scattering with strong interest in new developments (sync. and scanning) Hyogo the only running facility with combined carbon and proton therapy Reported patient treatments Proton = 2382 Carbon = 638 (20%) 18

19 RUNNING FACILITIES in the world EUROPE Type Rooms Acc. Start Pats. Company Uppsala S p200 1H sync Orsay F p230 1g1h cycl IBA sync.cycl. - new cyclotron+gantry operational since Oct 2010 PSI, CH p250 1g cycl. SC degraded beam until 2006; dedicated 250 MeV cyclotron since 2007 GSI Darmstadt D C430 1h sync stopped RPTC Munich D p250 4g1h cycl. SC Varian HIT Heidelberg D p250 2h sync started /Siemens HIT Heidelberg D C430 2h sync started The new European facilities are based solely on active scanning (except Orsay) Despite the fact that the organ motion problem with scanning is still unsolved Protons facilities are all with gantry (and cyclotron) Carbon facilities are only with horizontal beam lines (except HIT in Heidelberg) PSI and GSI have pioneered beam delivery by pencil beam scanning 19

20 RUNNING FACILITIES in the world RUSSIA ITEP, Moscow Russia p250 1h sync St.Petersburg Russia p1000 1h Dubna Russia p200 1h AFRICA Cape Town S-Africa p200 1h cycl CHINA WPTC, Zibo p230 2g1h cycl IBA? MPCAS, Langzou C400 1h sync Siemens? KOREA NCC, IIsan p230 2g1h cycl IBA 20

21 FACILITIES under construction USA Northern Illinois, p250 SCcycl 2g2h Varian?? PTCenter, Chicago p230 cycl 2h2dual fixed beams IBA HUPBTC, Hampton, V p230 cyclotron 4g1h IBA ProCure facilities (initiative of Indiana Un. ) New Jersey Seattle Florida Michigan coming soon TAIPEI Chang Gung Taipei Taiwan p235 cycl 4g1h JAPAN Southern Tohoku,Fukushima p230 cycl 2g1h Medipolis, Ibusuki Kagoshima p250 sync 3g RUSSIA PMHPTC, Protvino Russia p250 sync 1h?? New commercial machines for protons: all with passive scattering? 21

22 FACILITIES under construction EUROPE PSI P-Gantry 2, p250 1g cycl parallel scanning WPE, Essen Germany p230 3g1h cycl. IBA-scanning Trento Italy p230 1g1h cycl. IBA-scanning PTC Czech Rep. p230 3g1h cycl? CMHPTC, Slovak Rep. p250 1h synch? Heidelberg C-Gantry p,c430 CG sync. Scanning CNAO, Pavia Italy p,c430 3h sync. Scanning PTC, Marburg p,c430 3h145 sync. Scanning Siemens NRoCK, Kiel p,c430 1h 1(v45)1hv Scanning Siemens Med-AUSTRON p,c400 1pG,1h 1hv sync. Scanning 1 dedicated Proton Gantry New commercial machines in Europe: all based on scanning 22

23 The two centers pioneering pencil beam scanning in the last decade The gantry 1 of PSI (since 1996 ) Protons delivered with a cyclotron and a degrader The first scanning gantry in the world Discrete spot scanning (magnetic scanning range shifter patient table motion) Horizontal beam line at GSI (since 1997) Carbon ions - synchrotron with slow extraction 2D magnetic scanning dose painting in energy layers (fixed energy per pulse) Raster scanning technique (Beam stays ON from spot to spot) Same type of indications 23

24 Scanning developments in the USA At the new proton therapy facility in Houston One of the 3 gantries equipped with scanning First patient treated with proton pencil beam scanning on 19-May-2008 at the M. D. Anderson Hospital (Texas) Varian and IBA are now offering scanning-only based facilities 24

25 ACCEL VARIAN The RPTC in Munich The first industrial proton facility based solely on scanning Same accelerator as used at PSI Treating lung tumors with apnea under anesthesia 25

26 The University of Heidelberg Project Heidelberg Ion Therapy Center (HIT) The first and only gantry for carbon ions therapy in the world 600 tons Facility design by GSI Commercial partnership with Siemens Courtesy of Siemens And the University of Heidelberg, Germany 26

27 Rhön Klinikum AG - University of Marburg /Giessen The first commercial system for carbon therapy in Europe 4 identical horizontal beam lines for carbon ion treatments 110m Courtesy of Siemens and Rhön-Klinikum AG, Germany 66m 27

28 CNAO Centro Nazionale di Adroterapia Oncologica, Pavia, Italy Combined system for protons and carbon Initiated by Ugo Amaldi at CERN (TERA project) Synchrotron 3 areas with fixed beams One area with horizontal and vertical beam line Open possibility to expand the facility with proton gantries later Eventually a good idea 28

29 5. The strategy of PSI past experience and concepts for the future 29

30 The expansion of the PSI proton therapy project A new dedicated accelerator (superconducting cyclotron COMET) Treatments with Gantry 1 restarted in April 2007 A new Gantry 2 (for the further advancement of our scanning technology) Optis 2 (transfer of the eye treatments from Injector 1 to COMET) Medical cyclotron Optis 2 Degrader Gantry 2 Split beam Gantry 1 30

31 Continuation of the successful treatments with Gantry 1 15 patients/day (8:00-16:00) Clinically proven indications Base of skull and spinal chord and low pelvis Only non moving tumors (due to scanning) Excellent results Of great interest Pediatric tumors (1/3 patients) Below 5 years with anesthesia Gantry 1 is fully booked Not possible anymore to explore new indications Example of a child treatment under anesthesia at PSI Courtesy of B. Timmermann PSI 31

32 The cyclotron used as an active component for the beam delivery 250 MeV superconducting cyclotron (COMET) Delivered by ACCEL Varian in 2005 DC beam Very stable beam at the ion source Dynamic control of the beam intensity Deflector plate at the first turn of the spiral Control at a few 100 s time scale Fast dynamic energy changes With degrader and beam line 80 ms for a 5 mm step of proton range Much faster than with a synchrotron 32

33 Installations in the Gantry 2 area completed by the end of 2010 Gantry with sliding CT BEV X rays Parallel scanning The system which will be cloned in the Medaustron facility For proton therapy delivery 33

34 A new system for developing advanced scanning:. Double parallel magnetic scanning Continuous scan - speed up to of 2 cm / ms (equivalent to 2 khz pulses on a 5 mm grid ) Dose control through Dynamic modulation of the beam intensity (1mm = time scale of 100 s) Fast energy variations (for volumetric repainting) With degrader and beam line 80 ms per energy step (90 gantry magnet is the limit) Repainting capability Factor 10 compared to Gantry 1 Parallel scanning Beam intensity modulation Dynamic beam energy Repainting Gating Tracking Breath hold 34

35 6. New accelerator concepts 35

36 The dream solution Why not proton therapy like photon therapy? From Photon-Tomotherapy to Proton-Tomotherapy? Distal tracking? Rotational therapy with protons? (T.R. Mackie) High gradient (100 MeV/m) Linac (dielectric wall) Caporaso et al, Nucl Instr Meth B 261 (2007)

37 going for further simplifications? Very compact synchro-cyclotron (first beam extracted in 2010) Single room solutions for small size hospitals Still/River company (USA) Passive scattering Neutron background? How many compromises? Half a dozen of system already sold beforehand? ACCEL Varian Compact synchrocyclotron on gantry With degrader and beam analysis 37

38 New developments of accelerators related-to-therapy New interesting concepts Cyclinac: isotope production cyclotron coupled to a boosting Linac (Ugo Amaldi) Fixed Field Alternating Gradient (static beam line) FFAG Gantry (energy changes as fast as in lateral direction ideal for tracking?) Laser driven acceleration (how to control energy and dose simultaneously?) Plasma wake field acceleration?? Common to the mentioned solutions: the idea to provide Variable energy with the accelerator (to avoid the use of a degrader a big issue?) Short beam pulses To compete with a continuous fast scanning with a cyclotron (for repainting for mitigation of organ motion errors) one needs a High repetition rate of ~ 1 KHz? Control of the dose pulse by pulse: with pulse dose precision of < 1%? The general difficulty How can we reduce size and costs without loosing quality of beam delivery? 38

39 7. Conclusions 39

40 The general trend in hadrontherapy today in the world The field is booming Proton therapy Is a well established indications with more indications to discover: Developments towards treatments of moving targets (faster scanning) Exploration of hypo-fractionation Decision based only on the quality of the dose distribution (comparison protons-photons) Costs reimbursed by the health insurances Estimate: 10-15% of all radiation therapy patients should profit from protons Worldwide experience: patients treated with protons worldwide Equipment is available on a commercial basis how well optimized? Big industry entering the field Pencil beam scanning is accepted as a need yet available? For competing with IMRT 40

41 The general trend in hadrontherapy today in the world Carbon ion therapy A very interesting research topic (link to molecular radiobiology - a new field) Treatment reimbursed? More experience needed Total number of treated ion patients is only ~10% of hadrontherapy total Recently good results with hypo-fractionated lung treatments in Chiba Exciting results - but the comparison with hypo-fractionated protons is missing Ion therapy has more potential for surprises than protons (radiobiology) Ion facilities delivering ions and protons (mixed facility) Not fair to use protons at low quality, if this is only for cross-financing carbon therapy Yes, if proton therapy is properly done With a (proton) gantry? With nozzle optimized for proton therapy (for a small pencil beam) Very pleased that Medaustron is following this strategy Certainly a field with new things to discover 41

42 Thank you E. Pedroni Center for Proton Radiation Therapy - Paul Scherrer Institute Wien

A review of cyclotrons for Hadron Therapy. Y. Jongen Cyclotrons 2010 Lanzhou, September

A review of cyclotrons for Hadron Therapy. Y. Jongen Cyclotrons 2010 Lanzhou, September A review of cyclotrons for Hadron Therapy Y. Jongen Cyclotrons 2010 Lanzhou, September 10 2010 The early days The possible use of the Bragg peak of high energy ions in the radiotherapy of cancer was suggested

More information

Future dosimetry issues: protons, hadrons & MR linacs

Future dosimetry issues: protons, hadrons & MR linacs Future dosimetry issues: protons, hadrons & MR linacs Hugo Bouchard, PhD, MCCPM Senior Research Scientist Radiation dosimetry group National Physical Laboratory May 2014 Overview 1. Proton and hadron therapy

More information

An Introduction to Cancer Therapy With Hadron Radiation

An Introduction to Cancer Therapy With Hadron Radiation An Introduction to Cancer Therapy With Hadron Radiation Andrew M. Sessler Lawrence Berkeley National Laboratory Berkeley, CA 94720 April, 2008 Contents 1. History 2. X-Ray Machines 3. Why Hadrons? Which

More information

Introduction to Ion Beam Cancer Therapy

Introduction to Ion Beam Cancer Therapy Introduction to Ion Beam Cancer Therapy Andrew M. Sessler (with some slides from David Robin) Lawrence Berkeley National Laboratory Berkeley, CA 94720 Cyclotron 10, Lanzhou September 10, 2010 Contents

More information

PROGRESS IN HADRONTHERAPY

PROGRESS IN HADRONTHERAPY PROGRESS IN HADRONTHERAPY Saverio Braccini TERA Foundation for Oncological Hadrontherapy IPRD06 - Siena - 01.10.06 - SB 1 Outline Introduction Radiation therapy with X rays and hadrontherapy Hadrontherapy

More information

SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY

SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY SAVERIO BRACCINI * Albert Einstein Centre for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Sidlerstrasse

More information

Review of Hadron machines for cancer therapy

Review of Hadron machines for cancer therapy Review of Hadron machines for cancer therapy M. Kanazawa NIRS cancer therapy with hadron (p, C) Clinical studies at New ideas of accelerators Compact facilities (p, C) Depth dose distribution Carbon, proton

More information

Heavy Ion Tumor Therapy

Heavy Ion Tumor Therapy Heavy Ion Tumor Therapy Applications Bence Mitlasoczki 25.06.2018 Heidelberg 1. Source (H 2 /CO 2 ) 2. Linac 3. Synchrotron 4. Guide 5. Treatment rooms 6. X-ray system 7. Gantry 8. Treatment room with

More information

III. Proton-therapytherapy. Rome SB - 5/5 1

III. Proton-therapytherapy. Rome SB - 5/5 1 Outline Introduction: an historical review I Applications in medical diagnostics Particle accelerators for medicine Applications in conventional radiation therapy II III IV Hadrontherapy, the frontier

More information

Present Status and Future Developments in Proton Therapy

Present Status and Future Developments in Proton Therapy Present Status and Future Developments in Proton Therapy Alfred R. Smith Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030,

More information

REVIEW ON CYCLOTRONS FOR CANCER THERAPY

REVIEW ON CYCLOTRONS FOR CANCER THERAPY FRM1CIO01 Proceedings of CYCLOTRONS 2010, Lanzhou, China REVIEW ON CYCLOTRONS FOR CANCER THERAPY Yves Jongen#, IBA, Louvain-la-Neuve, Belgium Abstract The science and technology of proton and carbon therapy

More information

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Supervisors Prof. V. Patera PhD R. Van Roermund Candidate Annalisa Patriarca

More information

State-of-the-art proton therapy: The physicist s perspective

State-of-the-art proton therapy: The physicist s perspective State-of-the-art proton therapy: Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Overview of presentation 1. State-of-the-art proton delivery 2. Current challenges 3. New

More information

Review of Heavy Ion Accelerators for Hadrontherapy

Review of Heavy Ion Accelerators for Hadrontherapy Review of Heavy Ion Accelerators for Hadrontherapy Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences 11 th Int l Conf. on Heavy Ion Accelerator Technology,

More information

Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy -

Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy - Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy - Takeshi Murakami Research Center of Charged Particle Therapy National Institute of Radiological Sciences 2012.11.21 1. Introduction to

More information

Status of Proton Therapy: results and future trends

Status of Proton Therapy: results and future trends Status of Proton Therapy: results and future trends E. Pedroni Paul Scherrer Institute Division of Radiation Medicine CH-5232 Villigen PSI Abstract The number of centres investigating proton therapy in

More information

SUMITOMO Particle Therapy Technologies

SUMITOMO Particle Therapy Technologies 55 th AAPM annual meeting Particle Beam Therapy Symposium SUMITOMO Particle Therapy Technologies August 3, 2013 Yukio Kumata Experience accelerators for science Current Status proton and carbon Future

More information

Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May

Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May IONTRIS Synchrotron based PT Solutions from Siemens AG Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May 1 2009 Matthias Herforth VP Business Development and Communications Siemens AG

More information

The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center

The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center Thomas Haberer, Scientific Technical Director, Heidelberg Ion Therapy Center Situation / Indications 2/3 patients suffer

More information

A brief presentation of The TERA Foundation

A brief presentation of The TERA Foundation A brief presentation of The TERA Foundation David Watts on behalf of Prof. Ugo Amaldi and all my colleagues at TERA TERA Overview Direction: Prof. Ugo Amaldi AQUA (Advanced QUAlity Assurance) Cyclinac

More information

New Treatment Research Facility Project at HIMAC

New Treatment Research Facility Project at HIMAC New Treatment Research Facility Project at Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences IPAC10, Kyoto, JAPAN, 25th May, 2010 Contents 1. Introduction

More information

Proton and heavy ion radiotherapy: Effect of LET

Proton and heavy ion radiotherapy: Effect of LET Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer

More information

Proton Beam Therapy at Mayo Clinic

Proton Beam Therapy at Mayo Clinic Proton Beam Therapy at Mayo Clinic Jon J. Kruse, Ph.D. Mayo Clinic Dept. of Radiation Oncology Rochester, MN History of Proton Therapy at Mayo 2002: Decided to consider particle therapy analysis and education

More information

ACCELERATORS FOR HADRONTHERAPY

ACCELERATORS FOR HADRONTHERAPY ACCELERATORS FOR HADRONTHERAPY Alberto Degiovanni CERN-BE IVICFA s Fridays: Medical Physics Valencia, 31.10.2014 Introduction: the icon of hadrontherapy Position of the Bragg peak depends on beam energy

More information

Nuclear Instruments and Methods in Physics Research A

Nuclear Instruments and Methods in Physics Research A Nuclear Instruments and Methods in Physics Research A 620 (2010) 563 577 Contents lists available at ScienceDirect Nuclear Instruments and Methods in Physics Research A journal homepage: www.elsevier.com/locate/nima

More information

United States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022

United States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 United States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 United States Proton Therapy Market (Actual & Potential), Patients Treated,

More information

Proton Therapy Dosimetry & Clinical Implementation. Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine

Proton Therapy Dosimetry & Clinical Implementation. Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine Proton Therapy Dosimetry & Clinical Implementation Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine Outline» Proton Therapy Basics» Why Proton Therapy? (Dosimetric Superiority)»

More information

Proton Therapy Market Outlook - Global Analysis

Proton Therapy Market Outlook - Global Analysis Proton Therapy Market Outlook - Global Analysis Proton Therapy Market Outlook - Global Analysis BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen

More information

Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon

Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon Introduction Why Particle Therapy? PT Milestones What is meant by Industrialization Examples Protons-only:

More information

Particle Therapy- Why?

Particle Therapy- Why? Particle Therapy- Why? Kill tumour without affecting healthy cells X-Ray Therapy Head, neck, Spinal cord Eyes, orbits Pelvis Prostate Lung PEDIATRIC Proton Therapy Photon IMRT Photon Proton (Courtesy of

More information

Ion Beam Therapy should we prioritise research on helium beams?

Ion Beam Therapy should we prioritise research on helium beams? Ion Beam Therapy should we prioritise research on helium beams? Stuart Green Medical Physics University Hospital Birmingham NHS Trust Follow-up from the EUCARD2 workshop, ION Beam Therapy: Clinical, Scientific

More information

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania Proton Treatment Keith Brown, Ph.D., CHP Associate Director, Radiation Safety University of Pennsylvania Proton Dose vs. Depth Wilson,. R.R. Radiological use of fast protons. Radiology 47:487-491, 1946.

More information

Learning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan

Learning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan Overview of Quality Assurance in Proton Therapy Omar Zeidan AAPM 2012 Charlotte, NC July 30 st, 2012 Learning Objectives Understand proton beam dosimetry characteristics and compare them to photon beams

More information

8/1/2016. Motion Management for Proton Lung SBRT. Outline. Protons and motion. Protons and Motion. Proton lung SBRT Future directions

8/1/2016. Motion Management for Proton Lung SBRT. Outline. Protons and motion. Protons and Motion. Proton lung SBRT Future directions Motion Management for Proton Lung SBRT AAPM 2016 Outline Protons and Motion Dosimetric effects Remedies and mitigation techniques Proton lung SBRT Future directions Protons and motion Dosimetric perturbation

More information

The Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009

The Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009 The Heidelberg Ion Therapy Center Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009 Goal The key element to improve the clinical outcome is local l control! entrance channel:

More information

Treatment Planning (Protons vs. Photons)

Treatment Planning (Protons vs. Photons) Treatment Planning Treatment Planning (Protons vs. Photons) Acquisition of imaging data Delineation of regions of interest Selection of beam directions Dose calculation Optimization of the plan Hounsfield

More information

HEAVY PARTICLE THERAPY

HEAVY PARTICLE THERAPY HEAVY PARTICLE THERAPY DR. G.V. GIRI KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY ICRO 2012 BHATINDA HEAVY PARTICLES USED IN A EFFORT TO IMPROVE TUMOR CONTROL, THAT DO NOT RESPOND TO PHOTONS OR ELECTRONS BETTER

More information

TERA PROGRAMME: MEDICAL APPLICATIONS OF PROTONS AND IONS

TERA PROGRAMME: MEDICAL APPLICATIONS OF PROTONS AND IONS TERA PROGRAMME: MEDICAL APPLICATIONS OF PROTONS AND IONS Ugo Amaldi CERN, 1211-Geneva 23, Switzerland and TERA Foundation, Via Puccini 11, 28100-Novara, Italy Abstract The most recent applications of hadron

More information

Progress of Heavy Ion Therapy

Progress of Heavy Ion Therapy Progress of Heavy Ion Therapy Fuminori Soga Division of Accelerator Physics and Engineering, National Institute of Radiological Sciences, 4-9-1 Anagawa. Inage-ku, Chiba 263-8555, Japan 1. Introduction

More information

Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034

Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034 Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034 Saudi-Japan Business Opportunities Forum February 1 2, 2012 1 2 Types of Treatment Conventional Radiation Therapy Uses photons (energetic

More information

Present status and future of Proton beam therapy

Present status and future of Proton beam therapy Present status and future of Proton beam therapy Description At present, the types of proven treatment for cancer are surgery, radiotherapy, and chemotherapy. Depending on the characteristics of cancer

More information

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE I. Petrovi a, A. Risti -Fira a, L. Kori anac a, J. Požega a, F. Di Rosa b, P. Cirrone b and G. Cuttone

More information

NUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY. Pawel Olko Institute of Nuclear Physics Krakow Poland

NUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY. Pawel Olko Institute of Nuclear Physics Krakow Poland NUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY Pawel Olko Institute of Nuclear Physics Krakow Poland The NuPECC report: Nuclear Physics in Medicine http://www.nupecc.org/pub/npmed2014.pdf Outline 1. Why

More information

Planning for the Installation of a Compact Superconducting Proton Therapy Unit in a Busy Medical Center Environment

Planning for the Installation of a Compact Superconducting Proton Therapy Unit in a Busy Medical Center Environment Planning for the Installation of a Compact Superconducting Proton Therapy Unit in a Busy Medical Center Environment Barry W. Wessels, Ph.D. Director of Medical Physics and Dosimetry Case Western Reserve

More information

*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏

*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏 林口 Proton Therapy in Ti Taiwan *Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏 Chang Gung Memorial Hospital at Lin-Kou, Taiwan 林口長庚紀念醫院 OCPA2010 at Beijing, China Aug. 5, 2010 Outline 1. The principle of proton radiotherapy

More information

Look! Borg get upgrade already!

Look! Borg get upgrade already! Cancer, Partikel Terapi and PT accelerators Look! Borg get upgrade already! 1 Cancer, Partikel Terapi and PT accelerators Basic requirements to PT accelerator Accelerators for PT Siemens PT maskinen Alternativer:

More information

Chapter 41 New Facilities: Plans and Proposals

Chapter 41 New Facilities: Plans and Proposals Chapter 41 New Facilities: Plans and Proposals Ramona Mayer and Stanislav Vatnitsky Abstract Ion beam facilities that have either become operational since 2001 or are at present under construction or in

More information

H. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen

H. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen : Medical Operation of the 2 nd Machine, Production and Commissioning Status of Machines No. 3 to 7 H. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen VARIAN Medical Systems Particle

More information

OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY

OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY Abstract The CNAO (National Centre for Oncological Hadrontherapy) has been realized in Pavia. It is a clinical facility created and financed by the Italian

More information

Jefferies Healthcare Conference

Jefferies Healthcare Conference Jefferies Healthcare Conference Jean-Marc BOTHY - CSO June 8, 2017 2017 IBA SA Disclaimer This presentation may contain forward-looking statements concerning industry outlook, including growth drivers;

More information

Specifics of treatment planning for active scanning and IMPT

Specifics of treatment planning for active scanning and IMPT Specifics of treatment planning for active scanning and IMPT SFUD IMPT Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Treatment planning for scanning 1. Single Field,

More information

Applications of Particle Accelerators

Applications of Particle Accelerators Applications of Particle Accelerators Prof. Rob Edgecock STFC Rutherford Appleton Laboratory EMMA Accelerator at Daresbury Laboratory Applications >30000 accelerators in use world-wide: 44% for radiotherapy

More information

The Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center

The Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center The Heidelberg Ion Therapy Center and PARTNER Thomas Haberer Heidelberg Ion Therapy Center Goal The key element to improve the clinical outcome is local control! entrance channel: low physical dose low

More information

Nuclear Physics in Proton Radiotherapy

Nuclear Physics in Proton Radiotherapy Nuclear Physics in Proton Radiotherapy Cynthia Keppel, PhD Thomas Jefferson National Accelerator Facility (Hampton University Proton Therapy institute) International Nuclear Physics Conference Adelaide,

More information

PARTICLES. A Newsletter. for those interested in proton, light ion and heavy charged particle radiotherapy. T C P ROTON HERAPY O- PERATIVE ROUP

PARTICLES. A Newsletter. for those interested in proton, light ion and heavy charged particle radiotherapy. T C P ROTON HERAPY O- PERATIVE ROUP PARTICLES sponsored by P ROTON T C O G HERAPY O- PERATIVE ROUP for those interested in proton, light ion and heavy charged particle radiotherapy. A Newsletter Number 19 January 1997 Editor: Janet Sisterson

More information

Plans for the Precision Cancer Medicine Institute University of Oxford

Plans for the Precision Cancer Medicine Institute University of Oxford Plans for the Precision Cancer Medicine Institute University of Oxford STFC & Particle Accelerators and Beams group workshop on particle accelerators for medicine 17 th February 2015 Claire Timlin The

More information

Particle Therapy in the 21st Century: Relevance to Developing Countries

Particle Therapy in the 21st Century: Relevance to Developing Countries Applied Radiation Biology and Radiotherapy Section International Atomic Energy Agency Particle Therapy in the 21st Century: Relevance to Developing Countries Vienna International Centre Vienna, Austria

More information

Status of H 1 and C 12

Status of H 1 and C 12 Status of H 1 and C 12 Herman Suit No Conflict of Interest 1 Goal of a New Treatment Modality Tumor Control Probability or No in Complication Rate 2 Truism No Advantage to: any Patient for any Radiation

More information

CYCLOTRON PERFORMANCE AND NEW DEVELOPMENTS

CYCLOTRON PERFORMANCE AND NEW DEVELOPMENTS CYCLOTRON PERFORMANCE AND NEW DEVELOPMENTS Th.Stammbach, S.Adam, A.Mezger, P.A.Schmelzbach, P.Sigg PSI CH-5232 Villigen PSI, Switzerland Abstract New developments in the design and use of cyclotrons are

More information

IN VIVO IMAGING Proton Beam Range Verification With PET/CT

IN VIVO IMAGING Proton Beam Range Verification With PET/CT IN VIVO IMAGING Proton Beam Range Verification With PET/CT Antje-Christin Knopf 1/3 K Parodi 2, H Paganetti 1, T Bortfeld 1 Siemens Medical Solutions Supports This Project 1 Department of Radiation Oncology,

More information

Practical Challenges and Opportunities for Proton Beam Therapy. M. F. Moyers Loma Linda University Medical Center

Practical Challenges and Opportunities for Proton Beam Therapy. M. F. Moyers Loma Linda University Medical Center Practical Challenges and Opportunities for Proton Beam Therapy M. F. Moyers Loma Linda University Medical Center Outline I. Introduction II. Registration and Immobilization III. Beam Shaping IV. Localization

More information

Basic Press Information

Basic Press Information Basic Press Information Contact MedAustron EBG MedAustron GmbH Marie Curie-Strasse 5 A-2700 Wiener Neustadt Austria T +43 2622 26 100-0 e-mail: office@medaustron.at Internet: www.medaustron.at Press contact:

More information

Cell Survival vs Irradiation dose

Cell Survival vs Irradiation dose What have we learned from Radiation Treatment, and what I think will be the next generation ion therapy accelerators? S.Y. Lee, Department of Physics, Indiana University Cell Survival vs Irradiation dose

More information

Activities at the Heidelberg Ion Therapy Center (HIT)

Activities at the Heidelberg Ion Therapy Center (HIT) Activities at the Heidelberg Ion Therapy Center (HIT) The people A. Mairani (now INFN), F. Sommerer (Uniklinikum Heidelberg), I. Rinaldi (DKFZ Heidelberg), K. Parodi (HIT and University of Heidelberg)

More information

ABSTRACTS. of the NIRS International Seminar on the Heavy Charged Particle Therapy for Cancer and the XXVII PTCOG MEETING.

ABSTRACTS. of the NIRS International Seminar on the Heavy Charged Particle Therapy for Cancer and the XXVII PTCOG MEETING. P ROTON THERAPY C O- OPERATIVE GROUP Chair Michael Goitein Ph. D. Department of Radiation Oncology Massachusetts General Hospital Boston MA 02114 (617) 724-9529 (617) 724-9532 Fax Secret ary Janet Sisterson

More information

MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, *

MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, * Radiation Protection Dosimetry (2009), Vol. 137, No. 1 2, pp. 156 166 Advance Access publication 14 October 2009 doi:10.1093/rpd/ncp192 MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, * 1

More information

HADRONTHERAPY IN THE WORLD

HADRONTHERAPY IN THE WORLD HADRONTHERAPY IN THE WORLD Ugo Amaldi University of Milano Bicocca and TERA Foundation, Italy 1. CONVENTIONAL RADIOTHERAPY About one third of the 15'000 particle accelerators running in the world are used

More information

Economic Implications of Advancements in Radiation Technology. Dramatic Growth of RT Capacity in the US

Economic Implications of Advancements in Radiation Technology. Dramatic Growth of RT Capacity in the US Economic Implications of Advancements in Radiation Technology Sponsored by: OTN Anthony M. Berson, M.D. Radiation Oncology, St. Vincent s Comprehensive Cancer Center Richard Emery Vice President, Aptium

More information

Summary of Synchrotron for Hadron Therapy

Summary of Synchrotron for Hadron Therapy Summary of Synchrotron for Hadron Therapy April 30, 09 Koji Noda 1. G.H. Rees ; A New Tracking Gantry-Synchrotron Idea 2. K. Noda ; Overview of NIRS Accelerator Activity 3. T. Haberer ; The Heidelberg

More information

Integration of PT in an existing radiation oncology center

Integration of PT in an existing radiation oncology center Integration of PT in an existing radiation oncology center Tom Depuydt, PhD Head of medical Physics, Radiation Oncology UZ Leuven-KU Leuven and ParTICLe proton therapy project tom.depuydt@uzleuven.be 1

More information

Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC

Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC Radiation qualities in carbon-ion radiotherapy at NIRS/ Shunsuke YONAI Radiological Protection Section Research Center for Charged Particle Therapy National Institute of Radiological Sciences (NIRS) E-mail:

More information

Proton Stereotactic Radiotherapy: Clinical Overview. Brian Winey, Ph.D. Physicist, MGH Assistant Professor, HMS

Proton Stereotactic Radiotherapy: Clinical Overview. Brian Winey, Ph.D. Physicist, MGH Assistant Professor, HMS Proton Stereotactic Radiotherapy: Clinical Overview Brian Winey, Ph.D. Physicist, MGH Assistant Professor, HMS Acknowledgements Radiation Oncologists and Physicists at various institutions (MGH, MDACC,

More information

...some UK and Australian hadron therapy initiatives...

...some UK and Australian hadron therapy initiatives... Particles for patients, Radiotherapy with protons (and other ions): potential, problems and $$$s...some UK and Australian hadron therapy initiatives... David Thwaites Institute of Medical Physics Context

More information

PARTICLES. The deadline for the next newsletter is November , so that Particles 9 can come out in January Address all correspondence to:

PARTICLES. The deadline for the next newsletter is November , so that Particles 9 can come out in January Address all correspondence to: PARTICLES sponsored by P ROTON T C O G HERAPY O- PERATIVE ROUP for those interested in proton, light ion and heavy charged particle radiotherapy. A Newsletter Number 8 June 1991 Editor: Janet Sisterson

More information

Modelling the induction of cell death and chromosome damage by therapeutic protons

Modelling the induction of cell death and chromosome damage by therapeutic protons Modelling the induction of cell death and chromosome damage by therapeutic protons M.P. Carante 1,2 and F. Ballarini 1,2, * 1 University of Pavia, Physics Department, Pavia, Italy 2 INFN, Sezione di Pavia,

More information

The first year of operation of PSI s new SC cyclotron and beam lines for proton therapy.

The first year of operation of PSI s new SC cyclotron and beam lines for proton therapy. The first year of operation of PSI s new SC cyclotron and beam lines for proton therapy. Marco Schippers, Jürgen Duppich, Gudrun Goitein, Eugen Hug, Martin Jermann, Anton Mezger,Eros Pedroni, for the PROSCAN

More information

Proton and helium beams: the present and the future of light ion beam therapy

Proton and helium beams: the present and the future of light ion beam therapy Proton and helium beams: the present and the future of light ion beam therapy Dr. Andrea Mairani Group Leader Biophysics in Particle Therapy Heidelberg Ion Beam Therapy Center HIT Department of Radiation

More information

The Rise, Fall, and Rise Again of Proton Therapy or Never count out a well-financed therapy

The Rise, Fall, and Rise Again of Proton Therapy or Never count out a well-financed therapy The Rise, Fall, and Rise Again of Proton Therapy or Never count out a well-financed therapy Anthony Zietman MD Shipley Professor of Radiation Oncology Massachusetts General Hospital Harvard Medical School

More information

Considerations when treating lung cancer with passive scatter or active scanning proton therapy

Considerations when treating lung cancer with passive scatter or active scanning proton therapy Mini-Review Considerations when treating lung cancer with passive scatter or active scanning proton therapy Sara St. James, Clemens Grassberger, Hsiao-Ming Lu Department of Radiation Oncology, Massachusetts

More information

Proton Therapy: Where Are We Now and Where Are We Going? Erin Davis MSN, CRNP, ACNP BC Lead Nurse Practitioner

Proton Therapy: Where Are We Now and Where Are We Going? Erin Davis MSN, CRNP, ACNP BC Lead Nurse Practitioner Proton Therapy: Where Are We Now and Where Are We Going? Erin Davis MSN, CRNP, ACNP BC Lead Nurse Practitioner Genevieve Hollis MSN, CRNP, ANP-BC, AOCN Oncology Nurse Practitioner Advanced Senior Lecturer-B

More information

IMPT with Carbon Ions

IMPT with Carbon Ions IMPT with Carbon Ions PTCOG 48, Heidelberg, 28.09.-03.10.2009 Malte Ellerbrock Medical Physics Expert Heidelberg Ion-Beam Therapy Center HIT Betriebs GmbH am Universitätsklinikum Heidelberg http://www.hit-centrum.de

More information

HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS. Prof. Marco Durante

HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS. Prof. Marco Durante HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS Prof. Marco Durante Risk from neutrons Risk from exposure to fission spectrum neutrons has been extensively studied in the 60 s at nuclear reactors using animal

More information

CERN: from particle physics to medical applications. Manuela Cirilli CERN Knowledge Transfer Life Sciences Section

CERN: from particle physics to medical applications. Manuela Cirilli CERN Knowledge Transfer Life Sciences Section CERN: from particle physics to medical applications Manuela Cirilli CERN Knowledge Transfer Life Sciences Section The mission of CERN Research Innovation Push forward the frontiers of knowledge Develop

More information

Hampton University Proton Therapy Institute

Hampton University Proton Therapy Institute Hampton University Proton Therapy Institute Brief introduction to proton therapy technology, its advances and Hampton University Proton Therapy Institute Vahagn Nazaryan, Ph.D. Executive Director, HUPTI

More information

The national center for oncological hadron therapy: status of the project and future clinical use of the facility

The national center for oncological hadron therapy: status of the project and future clinical use of the facility Tumori, 95: 169-176, 2009 The national center for oncological hadron therapy: status of the project and future clinical use of the facility Roberto Orecchia 1, Piero Fossati 2, and Sandro Rossi 3 1 Università

More information

Global Radiation Therapy Market Report

Global Radiation Therapy Market Report Global Radiation Therapy Market Report ----------------------------------------- 2013 Executive Summary Radiotherapy is used to kill cancerous cells and is commonly used either alone or in combination

More information

Overview of Advanced Techniques in Radiation Therapy

Overview of Advanced Techniques in Radiation Therapy Overview of Advanced Techniques in Radiation Therapy Jacob (Jake) Van Dyk Manager, Physics & Engineering, LRCP Professor, UWO University of Western Ontario Acknowledgements Glenn Bauman Jerry Battista

More information

SHIELDING TECHNIQUES FOR CURRENT RADIATION THERAPY MODALITIES

SHIELDING TECHNIQUES FOR CURRENT RADIATION THERAPY MODALITIES SHIELDING TECHNIQUES FOR CURRENT RADIATION THERAPY MODALITIES MELISSA C. MARTIN, M.S., FACR, FAAPM PRESIDENT AAPM - 2017 PRESIDENT - THERAPY PHYSICS INC., GARDENA, CA MELISSA@THERAPYPHYSICS.COM AAPM Spring

More information

HADRONTHERAPY: a new frontier for cancer treatment

HADRONTHERAPY: a new frontier for cancer treatment Razionale HADRONTHERAPY: a new frontier for cancer treatment September, 19 20 2014 Hadrontherapy is a specific type of localized radiation therapy, which uses fast hadrons (charged particles made of quarks)

More information

Radiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada

Radiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada Overview Introduction Overview Introduction Brachytherapy Radioisotopes in contact with the tumor Overview

More information

Advances in external beam radiotherapy

Advances in external beam radiotherapy International Conference on Modern Radiotherapy: Advances and Challenges in Radiation Protection of Patients Advances in external beam radiotherapy New techniques, new benefits and new risks Michael Brada

More information

FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017

FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017 FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE Geoffrey S. Ibbott, Ph.D. June 20, 2017 1 DISCLOSURES My institution holds Strategic Partnership Research Agreements with Varian, Elekta, and Philips

More information

PARTICLES. A Newsletter. for those interested in proton, light ion and heavy charged particle radiotherapy. T C P ROTON HERAPY O- PERATIVE ROUP

PARTICLES. A Newsletter. for those interested in proton, light ion and heavy charged particle radiotherapy. T C P ROTON HERAPY O- PERATIVE ROUP PARTICLES sponsored by P ROTON T C O G HERAPY O- PERATIVE ROUP for those interested in proton, light ion and heavy charged particle radiotherapy. A Newsletter Number 18 July 1996 Editor: Janet Sisterson

More information

A Facility for Tumour Hadron Therapy and Biomedical Research in South-Eastern Europe

A Facility for Tumour Hadron Therapy and Biomedical Research in South-Eastern Europe SEEIIST South East Europe International Institute for Sustainable Technologies A Facility for Tumour Hadron Therapy and Biomedical Research in South-Eastern Europe U. Amaldi a, J. Balosso b, M. Dosanjh

More information

PRESCRIBING RECORDING AND REPORTING PROTON BEAM THERAPY ICRU 78. RAJESH THIYAGARAJAN Senior Medical Physicist & RSO Medanta The Medicity

PRESCRIBING RECORDING AND REPORTING PROTON BEAM THERAPY ICRU 78. RAJESH THIYAGARAJAN Senior Medical Physicist & RSO Medanta The Medicity PRESCRIBING RECORDING AND REPORTING PROTON BEAM THERAPY ICRU 78 RAJESH THIYAGARAJAN Senior Medical Physicist & RSO Medanta The Medicity HISTORY OF PROTON THERAPY Robert Wilson proposed the use of proton

More information

Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center

Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center The Heidelberg Ion Beam Therapy Center A Hospital-based Facility Dedicated to Precision and Flexibility Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center Carbon Ion Therapy

More information

Modern Hadron Therapy Gantry Developments. 16th Jan 2014

Modern Hadron Therapy Gantry Developments. 16th Jan 2014 Modern Hadron Therapy Gantry Developments 16th Jan 2014 Protect, Enhance, and Save Lives - 2 - IBA ProteusONE THE TREND: MORE COMPACT, CHEAPER Access to PT is key ProteusPLUS ProteusONE 18000 ft² / 1672

More information

ACCELERATOR DESIGN ISSUES IN CANCER THERAPY

ACCELERATOR DESIGN ISSUES IN CANCER THERAPY ACCELERATOR DESIGN ISSUES IN CANCER THERAPY December 25 P.J. Bryant CERN John ADAMS Memorial Lecture 25- P.J. Bryant - Slide 1 Contents Introduction Hadrons & voxel scanning Experimental setup A closer

More information

HIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN

HIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN HIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN S. Yamada, T. Honma, M. Kanazawa, A. Kitagawa, S. Kouda, M. Kumada, T. Murakami, M. Muramatsu, T. Nishio, K. Noda, Y. Sato, M. Suda and E. Takada, Research

More information